--- title: Acclinate’s Approach to Scaling Health Equity Through Innovation description: Discover how Acclinate is leveraging technology and community engagement to promote health equity and revolutionize clinical research. image: https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/Trust-Is-a-Two-Way-Street.jpg --- [![Acclinate Logo](https://blog.acclinate.com/hs-fs/hubfs/Acclinate-logo.png?width=2000&height=497&name=Acclinate-logo.png "Acclinate Logo")](https://www.acclinate.com/) - Products - [NOWINCLUDED](https://www.acclinate.com/products/nowincluded-the-community) - [eDICT](https://www.acclinate.com/products/e-dict) - Solutions - [Pharmaceutical Companies](https://www.acclinate.com/solutions/for-pharmaceutical-companies) - [Contract Research Organizations](https://www.acclinate.com/solutions/for-cros) - [Partners](https://www.acclinate.com/solutions/community-partners) - Company - [About Us](https://www.acclinate.com/about) - [Careers](https://www.acclinate.com/careers) - [News](https://news.acclinate.com) - Resources - [Resource Library](https://www.acclinate.com/resources) - [Blog](https://blog.acclinate.com) - [Press Kit](https://www.acclinate.com/press-kit) - [Events](https://www.acclinate.com/events) - [Glossary](https://www.acclinate.com/glossary) - [FAQ](https://www.acclinate.com/faq) - [Talk to Our Team](https://info.acclinate.com/get-in-touch) [![Talk to Our Team](https://no-cache.hubspot.com/cta/default/19943632/2e1c34dc-aaa1-43b8-b5f4-469b0db4e302.png)](https://cta-redirect.hubspot.com/cta/redirect/19943632/2e1c34dc-aaa1-43b8-b5f4-469b0db4e302) [![Acclinate Logo](https://blog.acclinate.com/hs-fs/hubfs/Acclinate_Logo.png?width=500&height=149&name=Acclinate_Logo.png "Acclinate Logo")](https://www.acclinate.com/) - Products - [**NOWINCLUDED**Acclinate’s B2C community platform ](https://www.acclinate.com/products/nowincluded-the-community) - [**e-DICT**Acclinate’s patented AI-powered technology ](https://www.acclinate.com/products/e-dict) - Solutions - [**Pharmaceutical Companies**Community-driven recruitment and real-world insights to support diverse, compliant clinical trials. ](https://www.acclinate.com/solutions/for-pharmaceutical-companies) - [**Contract Research Organization (CRO)**Scalable patient engagement and recruitment solutions that reduce risk and improve enrollment timelines. ](https://www.acclinate.com/solutions/for-cros) - [**Partners**Trusted partnerships that connect research opportunities with the communities they aim to serve. ](https://www.acclinate.com/solutions/community-partners) - Company - [**About us**We help clinical research teams reach diverse communities, build trust, and improve trial participation. ](https://www.acclinate.com/about) - [**Careers**Join a mission-driven team advancing inclusive clinical research and community-powered health innovation. ](https://www.acclinate.com/careers) - Resources - [**Resources Hub** ](https://www.acclinate.com/resources) - [**Glossary** ](https://www.acclinate.com/glossary) - [**Press Kit** ](https://www.acclinate.com/press-kit) - [**Events** ](https://www.acclinate.com/events) - [**Blog** ](https://blog.acclinate.com/) - [**News** ](https://news.acclinate.com/) - [![](https://cdn.prod.website-files.com/695fbca039298e2117988a78/69e7b588548c7ad7bd8ab0bc_9dd915489696393dc63d7785ee2e52c7_Question%20mark%20image.png) **FAQs** ](https://www.acclinate.com/faq) - [ Contact Us ](https://www.acclinate.com/contact-us) Stay up to date Get news directly in your inbox Topic All - [Affective Trust ](https://blog.acclinate.com/tag/affective-trust) - [Announcement ](https://blog.acclinate.com/tag/announcement) - [Clinical Research Software ](https://blog.acclinate.com/tag/clinical-research-software) - [Clinical Trial Recruitment Strategies ](https://blog.acclinate.com/tag/clinical-trial-recruitment-strategies) - [Community ](https://blog.acclinate.com/tag/community) - [Diversity in Clinical Trials ](https://blog.acclinate.com/tag/diversity-in-clinical-trials) - [e-DICT™ ](https://blog.acclinate.com/tag/e-dict) - [FDA Diversity Plan ](https://blog.acclinate.com/tag/fda-diversity-plan) - [FDA Guidance: Diversity in Clinical Trials ](https://blog.acclinate.com/tag/fda-guidance-diversity-in-clinical-trials) - [Health Equity ](https://blog.acclinate.com/tag/health-equity) - [Partnerships ](https://blog.acclinate.com/tag/partnerships) - [Representation in Healthcare ](https://blog.acclinate.com/tag/representation-in-healthcare) [Health Equity](https://blog.acclinate.com/topic/health-equity) # The Tech Behind Trust: Acclinate’s Approach to Scaling Health Equity Through Innovation Discover how Acclinate is leveraging technology and community engagement to promote health equity and revolutionize clinical research. ![patient and doctor talking](https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/Trust-Is-a-Two-Way-Street.jpg) Clinical Trial Diversity: What Does It Really Mean? Clinical trials are critical for evaluating the safety and effectiveness of medical devices and pharmaceutical products. The results of trials guide t... Read More ![ Leiselle Clark](https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/Leiselle-Clark.jpg) [Leiselle Clark](https://blog.acclinate.com/author/leiselle-clark) Head of Product, Acclinate Share this Post: [**](https://www.facebook.com/sharer/sharer.php?u=https://blog.acclinate.com/the-tech-behind-trust-acclinates-approach-to-scaling-health-equity-through-innovation) [**](https://twitter.com/home?status=https://blog.acclinate.com/the-tech-behind-trust-acclinates-approach-to-scaling-health-equity-through-innovation) [** ](https://www.linkedin.com/shareArticle?mini=true&url=https://blog.acclinate.com/the-tech-behind-trust-acclinates-approach-to-scaling-health-equity-through-innovation&title=Acclinate’s%20Approach%20to%20Scaling%20Health%20Equity%20Through%20Innovation) Stay up to date Get news directly in your inbox Automation. Predictive analytics. These are all technologies driving a new digital era. But can they also bridge longstanding health disparities? At Acclinate, we believe they can—when they’re designed with representation, cultural awareness, and community at the core, ultimately leading to more equitable healthcare outcomes and more effective clinical research for our sponsor partners. Technology alone won’t solve inequities in clinical research and healthcare at large. But when paired with trust, transparency, and user-informed design, it becomes a powerful catalyst for change. We're here to connect people to opportunity. To use technology to improve lives—not just processes. And to create a future where equitable clinical research isn’t the exception, but the standard.  In healthcare, we know the stakes are too high for innovation to be built in isolation. That’s why we begin every product conversation not with code, but with people. That’s what building [Affective Trust](https://blog.acclinate.com/why-affective-trust-is-essential-to-value-based-care) is all about. [![Download Now – Achieving Affective Trust: Actionable Insights Into Advancing Health Equity](https://no-cache.hubspot.com/cta/default/19943632/interactive-193539504024.png) ](https://blog.acclinate.com/hs/cta/wi/redirect?encryptedPayload=AVxigLLJFuOmQ86J%2BsHxEUe1dj5AxWF%2F4g38MUeF3cRuf6PGeAL4uLXWdzg0YYpH%2F0Vyv5ZNE8%2FPrQtJqxaiZIAZPFyTKMu4USwQqYfqzdk4rIaLZhVlffGQA1S0Ic9z1K6qsS5FgdxZHo5FXsbh%2F%2BMRxTghhiiGULWYfgVLYbG3oFSkow632LlHuSB5r2E29z6S82OJgCDRekN6GJBVQIU21Ch7557BcW7i6UW7e7z1IdQx3%2FzJRw%3D%3D&webInteractiveContentId=193539504024&portalId=19943632) ## **Trust Begins with Touch** At Acclinate, we don’t lead with tech—we lead with tech and touch . Before wireframing a single feature, we’ve spent hours in real conversations with community members, asking questions, listening to their needs, and learning from their lived experiences. We’ve always believed that *touch informs tech*. It’s one of the reasons our mobile app, launched in 2025, reflects exactly what our communities told us they needed: connection, accountability, and culturally relevant motivation to make healthy choices. The reality is people don't just want information. They want to connect with other community members. They want to hear each other, encourage each other, and access tools that make wellness feel accessible, not overwhelming. So, what did we do next? We built those features in. Not because a competitor was doing it, but because* people* asked for it. ### **Building for People, Not Personas** If you’re trying to improve equity in healthcare, you can’t build solutions based on generalized assumptions. You need real insights from the people you aim to serve. What’s the best way to collect this vital information? Treating technology users like partners, not numbers. Our user research and UX teams work side-by-side with community members in live focus groups. We dialog together. We test features live, in real time, because feedback should happen in the moment—not just through surveys. From these interactions, we continuously refine our product roadmap. We ask questions like: *Does this feature make your life better?* *Is it intuitive?* *Would you actually use it?* If the answer is no, we pivot. Because we’re not here to build for vanity metrics—we’re here to build for impact. ## **The Power—and Risk—of AI** Artificial intelligence holds enormous potential in healthcare, but it also carries risk. One of the biggest? Biased datasets that reflect the gaps of the past rather than the needs of the present. That’s why we built our own model—the **PPI (Participation Probability Index** **)**—based entirely on data from our own community. It helps us generate insights and predict engagement with clinical trials in a way that feels accurate, ethical, and aligned with the communities we represent. We don’t use AI to replace human judgment. We use it to enhance and organize what we already know to be true from our hands-on engagement. And because our team is as diverse as the people we serve, we bring lived experience into every layer of model development and validation. ## **Trust Isn’t Just External** It’s not just our users who trust what we build—it’s our team, too. Our product strategy is shaped by a diverse set of voices because we know the best products come from rich collaboration. Different perspectives don’t slow us down—they sharpen us. We ask better questions, anticipate more needs, and build stronger, more inclusive products as a result. Whether someone on our team comes from a healthcare background, tech, community work, or other, they bring insight that helps us create something meaningful. When you're trying to change an industry as complex as healthcare, you can't afford to have everyone in the room think the same way. ![doctor and patient tablet](https://blog.acclinate.com/hs-fs/hubfs/Acclinate/Blog%20Images/doctor-and-patient-tablet.jpg?width=1000&height=667&name=doctor-and-patient-tablet.jpg) ### **Tech That Scales Without Losing Humanity** As any product leader knows, scaling personalization is one of the toughest challenges. How do you keep that human feel as your user base multiplies? For us, the answer lies in transparency, communication, and the smart use of automation. We leverage AI to help personalize touchpoints, but we never let it replace relationship-building. We’re also deeply committed to **continuous feedback loops**. As we scale, we bring our communities with us. Whether through advisory boards, in-app feedback tools, or face-to-face focus groups, we keep asking questions. And we use technology to help us listen better—not just move faster. [Discover how Acclinate’s touch-first approach helped expand maternal and fetal health opportunities](https://www.acclinate.com/acclinates-equitable-maternal-fetal-health-innovations-case-study). ### **Supporting All Stakeholders with One Purpose** Acclinate operates at a unique intersection. On one side, we serve our community—helping individuals make informed, confident decisions about their health. On the other, we support our clients—clinical researchers and healthcare institutions—that need better tools to make trials more inclusive, efficient, and successful. The Acclinate advantage is that each side strengthens the other. When communities trust us, our insights become more accurate. When valued partners trust us, we can bring more opportunities to the people who’ve historically been excluded. When it comes to technology, we aren’t just partners. We act as a vital conduit. And it’s an honor to sit in that space, knowing the tools we build can lead to healthier lives, better outcomes, and generational impact. ### **For Product Leaders Trying to Build Trust** If you’re in the business of building technology for equity, here’s my advice: - **Be present.** You can’t design for communities you don’t engage with. - **Be curious.** Ask questions, then ask better ones. - **Be flexible.** The North Star doesn’t change, but your path might. - **Be bold.** Challenge assumptions—even your own. - **And above all, be human.** Because your tech will only be as trustworthy as the intent behind it. If you're not building *with* the people you're trying to serve, you're not building* for* them either. ## **Staying True While Scaling Up** Change is constant. In the past few months alone, [our industry has seen major shifts](https://blog.acclinate.com/the-case-for-inclusive-research-in-times-of-uncertainty). But through it all, we remain grounded in who we are and why we started this work. It’s not always easy. But the moments when we see that connection in action—like watching a friend extend her life through access to a clinical trial—make it all worth it. [When trust powers technology](https://acclinate-marketing-site-f2950ccfeaf088.webflow.io/achieving-affective-trust-actionable-insights-into-advancing-health-equity), real and long-term impact is possible. Ready to learn more about Acclinate's touch-first approach? [Contact our team](https://get.nowincluded.com/cs/c/?cta_guid=06387b94-c49a-4a46-9ace-10df11a46c52&signature=AAH58kF7b3Ny1osqHUy8plPlRJUgPxhKIQ&utm_referrer=https%3A%2F%2Fwww.acclinate.com%2Fcase-studies&portal_id=19943632&placement_guid=31583cc4-4449-4d4b-8cb9-94b6615b6eee&click=c6b1223d-4091-4d11-a5ee-abc90424f234&redirect_url=APefjpHnTTIQkxBlEg1ITgcAkQeZUcZcCLGLkj8iGDZHbTw03F-fvlB3gvOG1mB5PjA9L8YjgD_Xg9R_iFTOc1f7gx6SQ-QWkNJUNqqjzi3t8OK6jmZNSoKztUncMgMr6Pm4bRBc6R1A_bvvZHOGppef-I53IJ-MC80ujwgj7GairXyBAVxGDD2qRIO_33uFIZHfUDGuX7SAzhBTuHtOtzb9iE9riMNiwW6AJDmv3Y1eUIT2x4ASVrKF8xU-1Qh7xOgYoi_7GV6LRLmPTn5TPu75vDUl2Sc3Ow&hsutk=af2d6b60f434b25264f6c24b1b4bd070&canon=https%3A%2F%2Fwww.acclinate.com%2Facclinates-equitable-maternal-fetal-health-innovations-case-study&ts=1743871281338&__hstc=268225873.af2d6b60f434b25264f6c24b1b4bd070.1743791239896.1743791239896.1743870370996.2&__hssc=268225873.4.1743870370996&__hsfp=2562601565). [![Achieving Affective Trust:Actionable Insights IntoAdvancing Health Equity](https://no-cache.hubspot.com/cta/default/19943632/2daa6753-37c3-421c-a858-ea4e51d5f618.png)](https://cta-redirect.hubspot.com/cta/redirect/19943632/2daa6753-37c3-421c-a858-ea4e51d5f618) ## Recent Posts [![Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World](https://blog.acclinate.com/hubfs/mature-female-patient-at-doctors-appointment-2026-01-08-06-10-47-utc.webp) ](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world) [- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials) ](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world) [ Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World ](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world) June 25, 2026 3 Min Read Drug development economics are changing. Sponsors are increasingly relying on a single pivotal trial to support approval. Though the goal of this appr... Read More [![Clinical Trial Generalizability: What Regulators Will Scrutinize Next](https://blog.acclinate.com/hubfs/woman-visiting-dermatologist-2026-01-08-22-23-31-utc.webp) ](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next) [- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials) ](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next) [ Clinical Trial Generalizability: What Regulators Will Scrutinize Next ](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next) June 25, 2026 3 Min Read For years, generalizability was framed as a methodological concern. Reviewers debated whether results could reasonably extend beyond a trial’s enrolle... Read More [![Site Engagement Index (SEI): Measuring What Actually Builds Trust](https://blog.acclinate.com/hubfs/computer-screen-trading-and-back-with-charts-hom-2026-01-09-09-28-19-utc.webp) ](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust) [- [Clinical Research Software](https://blog.acclinate.com/news/tag/clinical-research-software) ](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust) [ Site Engagement Index (SEI): Measuring What Actually Builds Trust ](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust) June 25, 2026 3 Min Read Clinical research lacks anything but metrics. Enrollment targets, site activation timelines, and digital engagement rates are tracked closely across s... Read More [![](https://blog.acclinate.com/hubfs/Imported_Blog_Media/6567a9f90c0cf111067913e2_Merck%20Pop%20Up2.png) ](https://blog.acclinate.com/acclinate-collaborates-with-merck-to-increase-clinical-trial-diversity) [ Acclinate to support Merck's oncology clinical trials ](https://blog.acclinate.com/acclinate-collaborates-with-merck-to-increase-clinical-trial-diversity) June 24, 2026 1 Min Read Acclinate, an expert in health equity through inclusive research, is collaborating with Merck, known as MSD outside the United States and Canada, to h... Read More [![Why Trial Diversity Is Now a Risk Management Strategy](https://blog.acclinate.com/hubfs/Why-Trial-Diversity-Is-Now-a-Risk-Management-Strategy.jpg) ](https://blog.acclinate.com/why-trial-diversity-is-now-a-risk-management-strategy) [- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials) ](https://blog.acclinate.com/why-trial-diversity-is-now-a-risk-management-strategy) [ The New Control Lever: Why Trial Diversity Is Now a Risk Management Strategy ](https://blog.acclinate.com/why-trial-diversity-is-now-a-risk-management-strategy) March 2, 2026 3 Min Read For years, conversations around trial diversity were framed as ethical or reputational concerns. That framing no longer reflects regulatory reality. Read More [![Acclinate’s NOWINCLUDED: Turning Community Insights Into Research Equity](https://blog.acclinate.com/hubfs/AdobeStock_470269560.webp) ](https://blog.acclinate.com/acclinates-nowincluded-turning-community-insights-into-research-equity) [- [Community](https://blog.acclinate.com/news/tag/community) ](https://blog.acclinate.com/acclinates-nowincluded-turning-community-insights-into-research-equity) [ Acclinate’s NOWINCLUDED: Turning Community Insights Into Research Equity ](https://blog.acclinate.com/acclinates-nowincluded-turning-community-insights-into-research-equity) February 16, 2026 3 Min Read Clinical research equity efforts originate with good intentions. But they often hit a roadblock in practice: communities are asked to participate in h... Read More [![How Acclinate’s e-DICT™ Technology Builds Real-Time Community Trust](https://blog.acclinate.com/hubfs/AdobeStock_1631551849.webp) ](https://blog.acclinate.com/how-acclinates-e-dict-technology-builds-real-time-community-trust) [- [Community](https://blog.acclinate.com/news/tag/community) ](https://blog.acclinate.com/how-acclinates-e-dict-technology-builds-real-time-community-trust) [ How Acclinate’s e-DICT™ Technology Builds Real-Time Community Trust ](https://blog.acclinate.com/how-acclinates-e-dict-technology-builds-real-time-community-trust) February 9, 2026 3 Min Read Reaching underrepresented communities in healthcare research has never been simple. Participation decisions are shaped by lived experience, historical... Read More [![Data-Driven Inclusion](https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/Acclinate-Data-Driven-Inclusion.jpg) ](https://blog.acclinate.com/data-driven-inclusion-predictive-analytics-for-trial-enrollment) [- [Clinical Research Software](https://blog.acclinate.com/news/tag/clinical-research-software) ](https://blog.acclinate.com/data-driven-inclusion-predictive-analytics-for-trial-enrollment) [ Data-Driven Inclusion: Predictive Analytics for Trial Enrollment ](https://blog.acclinate.com/data-driven-inclusion-predictive-analytics-for-trial-enrollment) February 2, 2026 2 Min Read Subpar enrollment remains one of the most common causes of trial delays. But sponsors often miss a key factor: underrepresentation. Lack of diversity ... Read More [![Exploring Diversity in Clinical Research With Acclinate](https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/Exploring-Diversity-in-Clinical-Research-With-Acclinate.jpg) ](https://blog.acclinate.com/exploring-diversity-in-clinical-research-with-acclinate) [- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials) ](https://blog.acclinate.com/exploring-diversity-in-clinical-research-with-acclinate) [ Exploring Diversity in Clinical Research With Acclinate ](https://blog.acclinate.com/exploring-diversity-in-clinical-research-with-acclinate) January 26, 2026 3 Min Read Diversity in clinical research remains a widely discussed goal, yet progress has been uneven. Trials still grapple with subpar representation, limited... Read More [![Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World](https://blog.acclinate.com/hubfs/mature-female-patient-at-doctors-appointment-2026-01-08-06-10-47-utc.webp) June 25, 2026 Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World Read More ](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world) [![Clinical Trial Generalizability: What Regulators Will Scrutinize Next](https://blog.acclinate.com/hubfs/woman-visiting-dermatologist-2026-01-08-22-23-31-utc.webp) June 25, 2026 Clinical Trial Generalizability: What Regulators Will Scrutinize Next Read More ](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next) [![Site Engagement Index (SEI): Measuring What Actually Builds Trust](https://blog.acclinate.com/hubfs/computer-screen-trading-and-back-with-charts-hom-2026-01-09-09-28-19-utc.webp) June 25, 2026 Site Engagement Index (SEI): Measuring What Actually Builds Trust Read More ](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust) ![Woman wearing Acclinate Shirt](https://blog.acclinate.com/hs-fs/hubfs/layer1_image.webp?width=1600&height=1068&name=layer1_image.webp) ![Medical Research Software e-DICT](https://blog.acclinate.com/hs-fs/hubfs/layer2_image.webp?width=885&height=885&name=layer2_image.webp) ![layer2.2_image](https://blog.acclinate.com/hs-fs/hubfs/layer2.2_image.webp?width=1505&height=1197&name=layer2.2_image.webp) ![layer3_image](https://blog.acclinate.com/hs-fs/hubfs/layer3_image.webp?width=1600&height=1067&name=layer3_image.webp) ## Ready to Measure Your True Impact? Partner with Acclinate to turn mission into measurable, data-driven action. [ Get Started ](https://www.acclinate.com/contact-us) [![Acclinate Logo Reversed](https://blog.acclinate.com/hs-fs/hubfs/footer_logo.png?width=1600&height=398&name=footer_logo.png "Acclinate Logo Reversed")](https://www.acclinate.com/) - Products - [NOWINCLUDED](https://www.acclinate.com/products/nowincluded-the-community) - [e-DICT](https://www.acclinate.com/products/e-dict) - Solutions - [Pharmaceutical Companies](https://www.acclinate.com/solutions/for-pharmaceutical-companies) - [CROs](https://www.acclinate.com/solutions/for-cros) - [Community Partners](https://www.acclinate.com/solutions/community-partners) - Resources - [Resources Hub](https://www.acclinate.com/resources) - [Glossary](https://www.acclinate.com/glossary) - [Press Kit](https://www.acclinate.com/press-kit) - [Events](https://www.acclinate.com/events) - [News](https://news.acclinate.com/) - [Blog](https://blog.acclinate.com/) - [FAQs](https://www.acclinate.com/faq) - Company - [About us](https://www.acclinate.com/about) - [Careers](https://www.acclinate.com/careers) - [Contact Us](https://www.acclinate.com/contact-us) - Follow Us - [** Linkedin](https://www.linkedin.com/company/acclinateinc/) - [Privacy Policy](https://www.acclinate.com/privacy) - [Terms of Service](https://www.acclinate.com/terms-of-use-acclinate) ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Leiselle Clark", "url" : "https://blog.acclinate.com/author/leiselle-clark" }, "dateModified" : "2025-08-29T17:52:14.235Z", "datePublished" : "2025-04-15T14:00:00.000Z", "headline" : "Acclinate’s Approach to Scaling Health Equity Through Innovation", "image" : [ "https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/Trust-Is-a-Two-Way-Street.jpg" ], "mainEntityOfPage" : { "@id" : "https://blog.acclinate.com/the-tech-behind-trust-acclinates-approach-to-scaling-health-equity-through-innovation", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.acclinate.com/hubfs/Acclinate-logo.png" }, "name" : "Acclinate" } } ```